Three rounds of financing in a year, 300 million AI medical care is favored by capital
On April 2, Shenrui Medical announced that it has completed the B round of financing of 150 million yuan, led by Junlian Capital, Lenovo Star and Investment, A round and A+ round investment side Danhua Capital, Kunzhong Capital, Daoyi Investment, Crossing capital, Hongdao Capital continued to follow. So far, the company's accumulated financing amount of A round, A+ round and B round in the year of establishment has reached 300 million yuan, which is rare in the industry.
The 2018 work report of the two sessions mentioned the keyword of artificial intelligence many times. This year's government work report emphasizes “strengthening the application and development of a new generation of artificial intelligenceâ€, and the application of artificial intelligence has become the trend of the times. As a leader in the artificial intelligence + medical industry , Shen Rui not only promotes the technological innovation of artificial intelligence medical, but also promotes the application of artificial intelligence. It is understood that Shenrui Medical is deeply rooted in artificial intelligence + medical field, leading the breakthrough of artificial intelligence "deep learning" technology and building the world's top core algorithm technology. Shen Rui doctor artificial intelligence system, applying the latest technology of AI, the medical image disease diagnosis results have reached the international leading level. The product developed by the company and a number of scientific research institutions has been put into use by more than 100 hospitals. At the same time, with the strong support of Zhejiang University and its affiliated hospitals, Shenrui Intelligent will set up the Shenzhen Rui Aixiang headquarters artificial intelligence precision diagnosis and treatment center in April.
Li Jiaqing, the managing director of Junlian Capital, who is the leader of this round, pointed out that medical imaging is the most important clinical diagnosis and differential diagnosis tool in modern medicine. The continuous enrichment of imaging technology has made medical imaging from the auxiliary inspection tool to the current doctor's diagnosis. Nearly 70% of clinical diagnoses require medical imaging. The value of medical imaging AI lies in the efficient cooperation between clinicians and imaging doctors, reducing the rate of misdiagnosis. When data becomes a new production factor, artificial intelligence technology has created a new supply of medical services. However, artificial intelligence only has a single breakthrough in medical imaging. It is not enough to understand the medical industry's application to the product. Shenrui is a company in the field of AI imaging, scientific research level, engineering technology, product design, market sales, etc. The comprehensive medical AI technology companies with comprehensive capabilities are the best opportunities to stand out in the market competition.
Zhang Dadi, founding partner of A+ Wheel Investment, Danhua Capital China Fund, said that Shenrui is a company that is very rare in the AI ​​medical field and has a first-class artificial intelligence technology reserve and a deep accumulation and insight into the medical industry. An important factor in the success of a startup is its comprehensive ability. In particular, the threshold of the industry like medical care is very high, and the management of the startup team must have a foundation and influence in the industry. Shen Rui CEO Qiao Wei worked in the Siemens Medical Imaging Division for nearly 15 years and served as the general manager. He is a well-known veteran in the industry, has deep and clear understanding and insight into the medical imaging industry, and has managed a large team of hundreds of people. . Most of the core technical staff are from the BAT senior development team, many of whom have PhDs and strong R&D capabilities. Mr. Zhang Dadi is very optimistic about the Shen Rui team with Chaucer as the core. Such an elite team is fully committed to the domestic AI medical industry, which is full of opportunities. It has the conditions and strength of the industry leader and will definitely create a pattern and achievements. A unicorn business in the AI ​​medical field.
Wang Wei, the founding managing partner of Kunzhong Capital, who has led the round of investment and continued to vote with this round, believes that Shenrui's product line has made great progress in the past year. At the same time, the team of Shenrui has also been greatly enhanced, gathering a group of talents in the field of artificial intelligence, medical imaging, big data and other fields at home and abroad. Kunzhong has made extensive and in-depth layouts in the field of artificial intelligence. We believe this is a long track, and Shenrui has the potential to be a frontrunner.
It is reported that after the financing, Shenrui Medical will speed up the research and development of artificial intelligence products of various diseases, and accelerate the clinical inspection speed of artificial intelligence products.
Ultrasonic Scalers,Veterinarian Ultrasonic Scaler,Dental Ultrasonic Ucaler,Dental Ultrasound Scaler
Rolence Enterprise Inc. , https://www.rolencedent.com